For women with a history of ischemic stroke, use of vaginal estradiol tablets is not associated with an increased rate of recurrent stroke.

The FDA has extended the review for the BLA for clemidsogene lanparvovec for the treatment of MPSII, also known as Hunter Syndrome.

Higher carbohydrate intake is associated with increased MRI-detected vascular brain injury and reduced cognitive performance.

A remotely delivered behavioral intervention can reduce variability in systolic blood pressure, expressed as the coefficient of variation (BPCoV).

HealthDay News — Metabolic syndrome (MetS) is associated with an increased risk for Parkinson disease (PD), according to a study published online Aug. 20 in Neurology.

The FDA has issued a CRL to PTC Therapeutics regarding the NDA for vatiquinone for the treatment of children and adults living with Friedreich ataxia.

Families with a child receiving treatment for ASD incur almost 10 times more in health care costs than those of other children.

Risk for retinal vein occlusion (RVO) is higher among patients with obstructive sleep apnea (OSA), according to results of a retrospective cohort study published in Eye.

The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

Amyloid PET imaging is associated with significant changes in clinical management across a diverse patient population of older adults with cognitive impairment.

A discussion regarding the link between anger, stress and cardiovascular events with Dr Viola Vaccarino and Dr Elizabeth Vella.

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.